Alx Oncology Inc.
Clinical trials sponsored by Alx Oncology Inc., explained in plain language.
-
New combo therapy aims to outsmart resistant breast cancer
Disease control Recruiting nowThis phase 2 trial is testing whether adding evorpacept to standard trastuzumab and chemotherapy can shrink tumors in people with metastatic HER2-positive breast cancer who have already tried the drug Enhertu. About 120 participants will receive the combination intravenously. The…
Phase: PHASE2 • Sponsor: ALX Oncology Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New 'Smart Bomb' drug targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis early-stage study is testing a new drug called ALX2004 in people with advanced lung, head and neck, esophageal, or colorectal cancers that have not responded to standard treatments. ALX2004 is an antibody-drug conjugate designed to deliver a cancer-killing payload directly t…
Phase: PHASE1 • Sponsor: ALX Oncology Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC